Mechanisms of Immune Signaling in Colitis-Associated Cancer
Year: 2014
Type: review
Abstract: The inflammatory bowel diseases ulcerative colitis and Crohn's disease are associated with an increased risk for the development of colorectal cancer. During recent years, several immune signaling pathways have been linked to colitis-associated cancer (CAC), largely owing to the availability of suitable preclinical models. Among these, chronic intestinal inflammation has been shown to support tumor initiation through oxidative stress-induced mutations. A proinflammatory microenvironment that develops, possibly as a result of defective intestinal barrier function and host-microbial interactions, enables tumor promotion. Several molecular pathways such as tumor necrosis factor/nuclear factor-κB or interleukin 6/signal transducer and activator of transcription 3 signaling have been identified as important contributors to CAC development and could be promising therapeutic targets for the prevention and treatment of CAC.
Authors: Maximilian J. Waldner, Markus F. Neurath
Institution: Friedrich-Alexander-Universität Erlangen-Nürnberg
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: colitis-associated colorectal cancer, inflammatory bowel disease, ulcerative colitis, Crohn's disease, colorectal cancer, immune signaling pathways, chronic intestinal inflammation, tumor initiation, tumor promotion, intestinal barrier function, host-microbe interactions, TNF-α, NF-κB signaling, interleukin-6, STAT3 signaling, preclinical models, therapeutic target
Open Access status: hybrid
Estimated APC paid: $3,430
OpenAlex ID: W2066985016
